Fat-Derived stem cells injected into muscles in new myositis trial
NCT ID NCT04975841
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether stem cells taken from a person's own fat tissue are safe to inject into weakened muscles. Nine people with inclusion body myositis received injections in their forearm and thigh. The main goal was to check for side effects, not to measure improvement, though researchers hope this approach might eventually slow or reverse muscle weakness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
adipose-derived regenerative cells (stem cells from fat tissue)
What this could lead to
If safe and effective, this could point toward a treatment that slows or reverses muscle weakness in inclusion body myositis.
What could go wrong
This is a very early, small safety study with only 9 people. It is not designed to prove the treatment works, and larger trials are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCLUSION BODY MYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States